Skip to content

D-10 Hemoglobin A1C

by Bio-Rad Laboratories, Inc. 510(k)

Active United States

510(k) K031043

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK031043 Date27 Aug 2003ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

6 recalls · FDA

    • Terminated Z-1299-2014 FDA Class II initiated 27 Feb 2014

    On a rare occasion the D-10 software might generate an extra result by duplicating the result form the previous sample and the Sample ID/Injection number from the next sample.

    • Terminated Z-0965-2014 FDA Class III initiated 22 Nov 2013

    D-10 A1c Dual Program Floppy was programmed incorrectly and cartridge injections counts are not being updated correctly when switching between the D-10 Dual Short Program and Extended Program on the D-10 Hemoglobin Testing System.

  • 3 recalls, same reason

    • Terminated Z-0017-2012 FDA Unclassified (pre-2012) initiated 12 Sep 2011
    • Terminated Z-0019-2012 FDA Unclassified (pre-2012) initiated 12 Sep 2011
    • Terminated Z-0018-2012 FDA Unclassified (pre-2012) initiated 12 Sep 2011

    A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

    • Terminated Z-1969-2011 FDA Unclassified (pre-2012) initiated 8 Sep 2010

    The firm discovered that the Update Kit Floppy Diskette included in the reorder pack was mislabeled with an incorrect Lot Number for the Calibrator/Diluent Set as: S01819; The correct Lot Number for the Calibrator/Diluent Set is: S01704.

Specification

510(k)

510(k) Number
FDA Product Code
LCP
Device Class
Class II
Regulation
21 CFR Part 864.7470
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Bio-Rad Laboratories, Inc.

See all devices from Bio-Rad Laboratories, Inc. →